It’s Better to Hope for Prosperity than Become Adversary: Dada Nexus Ltd ADR (DADA) Stock
Daiwa Securities raised the price target for the Dada Nexus Ltd ADR (NASDAQ:DADA) stock from “a Buy” to “a Neutral”. The rating was released on May 16, 2024, according to finviz. The research report from New Street has downgraded the stock from Buy to Neutral, with a price target set at $2. The latest trade, […]
The idea of catching MoonLake Immunotherapeutics (MLTX) Stock might be a good one
Oppenheimer raised the price target for the MoonLake Immunotherapeutics (NASDAQ:MLTX) stock to “an Outperform”. The rating was released on June 25, 2024, according to finviz. The research report from Wolfe Research has initiated the stock to Outperform, with a price target set at $77. The stock was initiated by Citigroup, who disclosed in a research […]
It’s not the right time to quit: Canadian Solar Inc (CSIQ) Stock
Daiwa Securities raised the price target for the Canadian Solar Inc (NASDAQ:CSIQ) stock to “a Neutral”. The rating was released on March 11, 2024, according to finviz. The research report from JP Morgan has downgraded the stock from Neutral to Underweight, with a price target set at $22. In their research brief published March 10, […]
Top-line Growth is Likely to Be Driven by SkyWater Technology Inc (SKYT) Stock
TD Cowen raised the price target for the SkyWater Technology Inc (NASDAQ:SKYT) stock to “an Outperform”. The rating was released on February 27, 2024, according to finviz. We previously noted in another research note published on February 27, 2024 by Needham that reiterated the stock to a Buy with a price target of $15 for […]
Does Pediatrix Medical Group Inc (MD) Stock have plenty of room for growth?
Deutsche Bank raised the price target for the Pediatrix Medical Group Inc (NYSE:MD) stock from “a Sell” to “a Hold”. The rating was released on June 07, 2024, according to finviz. The research report from Stifel has resumed the stock to Hold, with a price target set at $30. The stock was downgraded by Deutsche […]
The Sable Offshore Corp. (SOC) Stock expansion path ahead
TD Cowen raised the price target for the Sable Offshore Corp. (NYSE:SOC) stock to “an Outperform”. The rating was released on February 26, 2024, according to finviz. The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated 4.36% within the last five trades and 0.20% within the last […]
Tandem Diabetes Care Inc (TNDM) Stock is poised for a successful quarter
Redburn Atlantic raised the price target for the Tandem Diabetes Care Inc (NASDAQ:TNDM) stock to “a Buy”. The rating was released on May 30, 2024, according to finviz. We previously noted in another research note published on May 22, 2024 by Citigroup that upgraded the stock from a Neutral to a Buy with a price […]
Facts about Mural Oncology plc (MURA) Stock that you might not know
Rodman & Renshaw raised the price target for the Mural Oncology plc (NASDAQ:MURA) stock to “a Buy”. The rating was released on June 28, 2024, according to finviz. The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated -3.09% within the last five trades and -6.27% within the […]
There is no better tap than ARS Pharmaceuticals Inc (SPRY) Stock
Leerink Partners raised the price target for the ARS Pharmaceuticals Inc (NASDAQ:SPRY) stock from “a Market perform” to “an Outperform”. The rating was released on March 05, 2024, according to finviz. The stock was initiated by Wedbush, who disclosed in a research note on January 31, 2023, to Outperform and set the price objective to […]
A healthy upside potential exists for Alto Ingredients Inc (ALTO) Stock
The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated 12.89% within the last five trades and -2.36% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price decreased -48.21% in the last 6 months […]
